Member Info for Bushmaster

Bangbangchicken, exactly on the nail.

cl81227 - Can't argue with your post. The issue surrounding social media, Twitter being the choice for most is that a lot of companies feel they are under pressure to inform investors, nothing sensitive, just re-hashed info to keep the PI's from not selling out. For months and months a lot of investors wanted tweets, wanted news, rather than just waiting for the official channel, the RNS - This is the result, Omega using Twitter and not fully understanding the impact, positive or negative.

Who gave the green light for a Friday night tweet needs to have their head wobbled, stuck in a bucket of water, with a apple inserted into the mouth, and kicked up the arse by all PI's. Elon Musk can move a market, is that the reference to Tesla, someone trying to be clever and link themselves to EM, why mention Tesla out of all the blo-doy cars on the market!

gkb47, I think so. All started last night because someone smoke some Wedding Cake! Best take the day off Omega, you are doing are heads in.

Computer909, morning. I don't always agree with you, but this time I think you are bang on the money. Everyone over the last few months screaming for Tweets, and this is what you get, a rollacoaster....They really should employ someone who has a lot of knowledge in PR (PM me Omega) there are ways to skin a cat and the last few weeks is not the way.

Ever who is tweeting does either not understand the effect of SM on the SP or does - if its the latter that would really be a game that should not be played.

Pictland, I used the example of Sports Direct, pick JD, could be any high street chain. Whether that is part of the strategy or not I do not know. But what I do know, this is a numbers game. I do agree the likes of Space NK and CultBeauty can be utilised, even working with Deepverge and tapping into their concept. You can sell into chains of gyms, spas and sports clubs as suggested, but with all these supply chains there needs to be message attached. I don't see product (s) arriving at a gym (example) and then it sits on shelf? Who promotes this product to the gyms clients, the staff. Possibly, that means all distrubtion chanels will need staff training, whatever retail enviroment the product lands into selling a new range of CBD will not be easy. If this is the case, then the cost of product will be high. I know Space NK pretty well, I know their staff are trained, have a knowledge of numerous products - Who is pushing sales in these stores, the staff when asked? POS, well that means shelf space and on it goes.

If CBX are going to push the premuim angle with a higher RRP tag, its going to be for me a risky strategy in the sense of not knowing what the competition will do, or how they will react. Its not difficult to bring product out, nor is it difficult to white label, not in this game and not where we are today. Buyers for chains etc will be on the look out for similar product, more affordable RRP entry points to satisfy their end user, Sephora use cheaper ranges to push their higher aspirational ranges.

I agree with Amran, I have said this a few times. Marketing, price point along with POS is going to be key. Premuim products mean higher earners, that does not equate to large numbers, but what it does do is burn cash at a high rate through marketing. Premuim = aspirational, that comes with its own problems short term.

The advantage of using chains such as SD is its mass volume, I wouldn't suggest dumping the full range, but having a product or two in chains such as these gets the brand message out. There is a reason the likes of Nike etc use the likes of SD etc. I don't believe there is anything wrong with this approach, it will certainly be cheaper than a full on marketign campaign with zero guarantees of ROI, if and I say if, the CBX range is premuim with all that entails then you need a product (s) that is affordable, is not in the higher end stores and is used as a introduction to the main range.

Lots of companies use this strategy, Mulberry used this with great success, even Range Rover brought out the Evoque due to the higher end RR Sports price tag and on it goes.

I am also quite interested to see how/if the crypto angle is used online or part of a strategy in store for their distrubtion channels - There is definaltly some good PR based around taking crypto/BTC for your CBD products.

obstando, I take your point on ZOE. Love Hemp I am not sure, its not that difficult to white label, do some fancy packaging and take to market. The reason for my thinking on LH is due to their distrubtion chain already in place, unlike CBX and I will add ZOE to the list. UFC is one strand, they have others, will they compete in other products, I can't see why not. Pureis etc etc, there are many that is for sure. Do these companies have the cash resources to supply into major chains (I presume this is part of the CBX strategy) and keep that going, I am not sure. If we take DB on face value, the sports angle and take Sports Direct as a example stockest, the company supplying in will need to show its sitting on stock, can deliver and will put money into a marketing strategy to drive traffic to SD. We know branding in this market is everything. Plus a company like Sports Direct will want an account, 30/60 days. I would also suggest the US suppliers will not want to be financing CBX. All this takes cash flow and lots of it.

Its a big arena as you say. Will CBX and others being listed help them open doors, having decent BoD's will also help. How this impacts on non listed companies such as Pureis, Voyager etc is diffiult to judge, but there will be a negative impact for them if they are tendering for the same contracts. Having a company listed is easier to raise capital, so its easier to grow a company quicker if you start to win big contracts that are going to need finance. As you rightly suggest its down to the CBX BoD to keep to their targets and I do think this will do well long term.

Computer909 - Obviously I should have taken him on face value ! Why, that was not my point, don't get your comment. For every action, there is usually a re-action, that was my point.

Takayama, who are these other players in CBX sector? I don't understand the small fish pond comment?

I don't see ZOE as compo either, the US markets seems to ge their overall focus.

MGC, KNB you can exclude. Love Hemp are what I would call competiton for CBX, short and long term. NL I agree, 25K min from investors as you say, but not from any bank. Maybe I should of been clearer, yes you can get investors to invest, placings (I think there as a 25% discount on NL via CLN) and hence why they want to float - The cannabis industy is not like any other business, you could have the best business plan, no bank will loan you the funds currently for CBD or especially high grade THC flower, so I don't agree with that comparison. Back to NL, they want to produce flower, 'they want' and are not currently doing so for THC med cannabis, so for me there is no comparison, not saying you made that point :) They were oversubscribe, but investors are looking at them and comparing GWP, EMMAC, Tilray, that is going to be NL compo and they are a long way off from giving any of those 3 a run for their money. Not to see when they float in Q4 there won't be money made by investors.

Front of the queue comment - For their business model I think they are, who is in front of CBX, or side by side?

JAdam " He has suffered less than 1/10th of 1% of the abuse I have here" give me a break, this BB isn't all about you and how hard you have it! I can't actually believe you wrote that cr-ap. The reason you got a little bit of non love is because you are two faced, its as simple as that. You are what are, but keep the hard done by cr-ap in your desk draw.

I see BJ post got 80 odd recommends, not bad considering all the flack he took. Computer909, that is a list, problem with these lists and I am not doubting its untrue, (I have no idea but you have made the effort to post it so unless anyone has the time to disaprove it, I take it as face value) is that it does not state what happened before hand - What was BJ responding too, insults, criticism, personal digs at his family as we saw over the last few days. I am sure he is no angel, who is? Or has he written those words without previous comments/digs call it want you want from whom he is responding too......

PS - I can't believe someome has taken the time to trawl someones history to put that list together, anyone else find it bizaare!

Takayama, its going to be competitive. As the previous poster mentioned, look at the US. I would suggest look at Canada instead due to the full legislation rather than the 'part' that the US has. I personally don't think its 12 months, over the next 3 to 3 years a lot of new players will come in, most will not make it, or they will need big investors backing them. If you look at the big players listed in the US/Canada who is making money, 1 or 2. The rest are running big debt margins and are hoping for a buyout, its very very hard currently to raise cash from banks or private institutions etc. Hence why they listed on various markets. It is still very early days for the cannabis industry no matter what you read. The US is the real deal breaker, once they go legal on a FED level then the companies at the fore front will be the real winners.

CBX have raised a decent amount of cash, that puts them in the front with the likes of Love Hemp, have a good BoD and for the sector they are targeting puts them right at the front of the queue. The other big factor IMO will be legislation in the UK/Europe, as CBD starts to become more and more mainstream the 'law' will need to keep up, bigger costs will be involved, contracts harder to get etc etc.

Bigjock36, not surprised. This BB has turned into a shxthole, no wonder most have buggered off. GL to you and yours.

HarryCaul, as we know there are the 'big boys', being discussed on this thread. That is not to say others do not want in, this is a fluid, no-one is sure what this will turn into, who the BoD are having discussions with. My point being there could be and we would hope so other larger share holders who want to hold, due to these possible new discussions. I think its natural to assume if that is the case the MM's will bring the price down to fill X order, or bring it down to attact new investers (as over the last 3/4 weeks) so the sellers can keep selling out. Even if there are no orders to fill, you need buyers, no news, its natural the price will drift downwards but the process remains the same.

EkXoc, post of the hour, that is the problem. I think Gordon Welchman needs a mention.

Northseatiger1, I don't think you need to post to own shares. I have a bit of Orph, read the BB from time to time, I can't even remember if I have posted. Half my shares I don't post on the BB, GSK, IE3, EQT to name a few.

LSE is a mad show, personally I have been in shares since GWP, that is a long long time ago. Joined LSE back in Oct ish, Covid being the main reason due to lockdown. IMO, there are some very helpful members, lots of knowledge and the odd nugget from one or 2, and you try and give back a few. I do agree with earache, self moderation on certain boards happens due to the way LSE admin are hands off, to be fair to them its impossible to run LSE.

Back to the main meal, SPAC and what the next move is, I think that is why we are here. GLA

Computer909 - Capacity is the right word, unless you are commited contractually, then you need to deliver. One thing is for shxt sure, we are going to find out very soon how the land lies. As for the 'statistical exercises' that is dodgy ground to be on. If they are led by science, then science tells us currently they believe the vaccine is good for 6 months, but in the real world that cannot equate to everyone. Are we saying on month 6 the stats tell us to run to the tent for a jab, I can't see it myself. Everyone one will have different rates of antibodies, when a test needs to start to check is the real question, and then how many after that will each person need before they have a top up booster, or a re-jigged Vac - That is what is goint to call the numbers on these tests, I can't see one company having the market, preferred or not.

Computer909 - Not sure you can compare SourceBio to Omega, their turnover before this was a lot higher as well as their SP. EFK I haven't looked for a while, that turnover, is that from 19/20? I wasn't aware 20/21 full year revs where out yet. Do you know their gross profit % and net on their balance sheet?

If you are right on the ABC test, not sure where that puts them. "we hope now for further use in a surveillance roll, but that is likely to be a very much smaller statistical based use" Are you saying this will not be rolled out to know when a individual will need to either have a booster or a new vac due to new variants?

We don't know what test, but maybe CK does already, if not, then what have they been manufacturing, either something or nothing - Omega have stated in an RNS/tweets that they will be able to, or will be manufacturing 2 million per week, whether this is end of April or the 1/2nd week in May is unclear. But at the moment, the fact is this what the company has stated.

The SP I agree, seems to me its being traded and with no II's on board its been up and down more times than a seesaw in the last few months. I think its clear the market needs to know what the initial contract (s) are for a re-rate. Not sure on the narrative comment, park the TT, its been pretty consistent in terms of what is going on, numbers expected to manufacture etc since Jan. I also think many LTH's from back in April/May last year are more than happy, hard to moan about the rise up till Nov last year. Bear in mind we got hit with everyone else on the first Vaccine news, that did no favours to the SP which was in sicking around the 90's.

I am hoping once we get contract RNS's, II's will come in, a few TR1's will settle the SP down and give some confidence to nervous PI's.

Computer909 - Its hard to argue with the loss of the face of it, it is a loss. What I would say is they have done zero business, is that not down to getting to this point we are today, with everything that has gone on before. For me that is the logical answer. If they had LFTs as Innova had them, then we would be in a different ball. That fact is they didn't, from what I can see no-one in the UK was set up.

The companies you mention, are they in the same industry?

Do you not think the ABC/Antigen was always going to come into play once the vaccine had been given?

Elisa, I take your point.

TT, that has taken a lot longer, why I have no idea. I also think CK is now a lot more cautious in what he states, due to what he said back in Nov/Dec, pushed by CK the TT would be done early on in the new year. I think he has learnt from that, best say nothing until its done. Its been a big stick used by many to hit the company with, which has effected the SP, I don't think anyone can argue with that.

Apart from the TT, Elisa, a few others come to mind, I can't see how this has come up short. I can see the frustration, but as I said on the earlier post, a lot has taken place in 12 months. We either believe in what CK says, ie: contracts, production at 2 mil a week or not, that is the botton line.

We also don't know what stock has been manufactured, what tests and how much they are sitting on in stock, if any. Depending on what you believe and read on various boards etc, its not a lot, or close to 10 million - If this is the case, would it been better to of sold what is (if) being produced and let us shareholders know, maybe, would the SP be in a better postion, no idea.

I don't know what the CK business model/plan is that has got them to where they are today, but we either trust them or we sell out, its one or the other until the RNS's drop.

Vascular, good post.

Computer909, I am struggling to understand why Omega have come up short, time and time again? Its more or less 12 months since Covid hit, they had no postion to manufacture, no machines, no staff to deal with the demand, no nothing. So in 12 months they have gone from zero to where we are today. If this was going on for years like a lot of other companies, granted, I get your point, but its 12 months.

From a pure business point of view that is pretty dam good, considering we think/been told there are big contract (s) coming in. You can argue all day long about communication, but 12 months to set all of this up, recruiting, new building, new machines, new suppliers, contract negotiations etc etc...I think they have done pretty well.

Johnski, LSE BB's can be a tough for many, money always brings out the best in people. I wouldn't sell out on another users post, either respond or ignore. There are filter buttons on LSE. I think Earache has some good knowledge, he/she has probably been round the block several times on LSE, but this is the world of LSE, way to many sharks and charlatans. Its not the 1st time Earache has gone off on one, sure it won't be the last, sounds like he has bitten the wrong end of the carrot, down to him/her to decide to suck it up and aplogise or not, GL to you.

Rach80, I reckon you can look after yourself, this is one of the more friendly boards, when/if this goes wait too see what users rock up. GL.

Benny-Hill, I know. It jsut pi-s-s-es me off that these type of posters just want to literally scr-ew people out of money. I have no idea on what type of effect it has on the SP, a read a lot it has none, but I can see organised groups posting negative comments, I can also see users on this board with more than one ID, its obvious from the way they type their messages. It must have an impact, which has to be a gain for them, otherwise why do, fxcking bizaare way of making a living .